Cell and gene therapy regulation: take the survey

Cell therapy Gene therapy Regulation & policy

To kick off our Spotlight on cell and gene therapy regulation, we want to know your opinions and insights.

Take part in our short survey, which covers critical stages of the regulatory journey, including early development, scale-up to manufacturing, GMP readiness, supplier qualification and the adoption of advanced compliance tools. We want to see where we are now, what challenges the community is facing and what the future may hold for the field.

Plus, one lucky participant will receive a US$50 voucher or donation to a charity of their choice*.

*Please note, only full survey responses will count as an entry into the prize draw.

This survey is part of the RegMedNet Spotlight on cell and gene therapy regulation. Click here to view the full feature and discover expert insights on this >>>